• Cisapride (R 51619): Nonselective 5-HT4 Agonist & hERG Ch...

  2026-01-09

  Cisapride (R 51619) is a nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor, widely used in cardiac electrophysiology and predictive safety research. This article details its validated mechanisms, evidence benchmarks, and integration into high-throughput in vitro workflows, enabling precise assessment of arrhythmogenic risk and serotonin-mediated signaling.

• Amiloride (MK-870): Applied Workflows in Sodium Channel R...

  2026-01-08

  Amiloride (MK-870) empowers researchers to dissect epithelial sodium channel and urokinase receptor pathways with precision, enabling reproducible results in cellular uptake and disease modeling. Its dual inhibitory action and robust performance make it the gold standard for ion channel and endocytosis studies, particularly in models of cystic fibrosis and hypertension.

• Otilonium Bromide (SKU B1607): Scenario-Driven Solutions ...

  2026-01-07

  This article provides an evidence-based, scenario-driven overview of Otilonium Bromide (SKU B1607) as an antimuscarinic agent for neuroscience and smooth muscle assays. Drawing on reproducibility, solubility, and workflow compatibility, we address real laboratory challenges and illustrate why B1607 from APExBIO is a robust resource for cholinergic signaling studies.

• Lamotrigine: High-Purity Sodium Channel Blocker for CNS a...

  2026-01-06

  Lamotrigine, a high-purity sodium channel blocker and 5-HT inhibitor, is widely used in anticonvulsant drug research and translational neuroscience. Its validated in vitro assay performance and robust BBB permeability profile make it a gold-standard tool for epilepsy and cardiac sodium current modulation studies.

• Nadolol (SQ-11725): Solving Real-World Assay Challenges i...

  2026-01-05

  This authoritative guide addresses persistent laboratory challenges in cardiovascular research, focusing on cell viability and beta-adrenergic signaling workflows. Discover how Nadolol (SQ-11725) (SKU BA5097) from APExBIO empowers biomedical scientists with reliable, evidence-backed solutions, improved reproducibility, and optimized assay performance.

• Cisapride (R 51619) in Predictive Cardiac Toxicology: Int...

  2026-01-04

  Explore how Cisapride (R 51619), a nonselective 5-HT4 receptor agonist and potent hERG potassium channel inhibitor, is revolutionizing predictive cardiac electrophysiology and toxicology research. Uniquely, this article delves into the synergy between deep learning, iPSC-derived cardiomyocytes, and advanced screening workflows for next-generation drug safety assessment.

• Otilonium Bromide: Precision Antimuscarinic Agent for Neu...

  2026-01-03

  Otilonium Bromide offers unmatched selectivity and solubility for neuroscience and smooth muscle research, empowering reproducible modulation of cholinergic signaling pathways. With robust acetylcholine receptor inhibition and high purity, this APExBIO reagent supports advanced experimental design and workflow reliability.

• Lamotrigine at the Translational Frontier: Mechanistic In...

  2026-01-02

  Explore how Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) is redefining translational research at the intersection of sodium channel blockade, serotonin inhibition, and advanced blood-brain barrier modeling. This thought-leadership article goes beyond product features—integrating mechanistic depth, experimental best practices, and future-facing strategy to empower researchers in epilepsy, cardiac, and CNS drug discovery.

• Otilonium Bromide: Antimuscarinic Agent for Neuroscience ...

  2026-01-01

  Otilonium Bromide stands out as a high-purity antimuscarinic agent, enabling precise modulation of muscarinic receptors in neuroscience and smooth muscle studies. Its robust solubility, receptor selectivity, and reliable inhibition of cholinergic signaling pathways make it an essential tool for advanced experimental workflows and translational models.

• 2,5-di-tert-butylbenzene-1,4-diol: Precision Tool for SER...

  2025-12-31

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) delivers unmatched control over SERCA-mediated calcium transport, empowering researchers to dissect calcium signaling pathways, drive hematopoietic stem cell mobilization, and model vascular smooth muscle dynamics. This guide translates latest experimental insights into actionable workflows and troubleshooting strategies—maximizing the impact of BHQ sourced from APExBIO in both basic and translational research.

• 2,5-di-tert-butylbenzene-1,4-diol (BHQ): Beyond SERCA Inh...

  2025-12-30

  Explore how 2,5-di-tert-butylbenzene-1,4-diol (BHQ), a selective SERCA inhibitor, enables advanced calcium signaling research and systems-level insights into muscle relaxation and stem cell mobilization. This article uniquely integrates molecular mechanisms with translational applications, setting it apart from standard overviews.

• Lamotrigine: High-Purity Sodium Channel Blocker for Epile...

  2025-12-29

  Lamotrigine, a high-purity sodium channel blocker and 5-HT inhibitor, is pivotal in epilepsy and cardiac sodium current research. Its validated solubility profile and stability enable reproducible in vitro assays, supporting rigorous CNS drug development. This article details mechanistic underpinnings, benchmarks, and workflow integration for Lamotrigine (SKU B2249) from APExBIO.

• DIDS: Precision Chloride Channel Blocker for Advanced Res...

  2025-12-28

  DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) is transforming chloride channel research with highly specific inhibition profiles, enabling breakthroughs in cancer, neuroprotection, and vascular physiology. Discover stepwise workflows, advanced applications, and troubleshooting strategies that set DIDS apart in translational studies.

• Spermine: A Master Regulator of Ion Channels and Nuclear ...

  2025-12-27

  Explore how Spermine, an essential endogenous polyamine, orchestrates inward rectifier potassium channel modulation and nuclear envelope remodeling. This article reveals novel mechanistic insights and scientific applications in cellular metabolism research, distinguishing itself from prior literature.

• Lamotrigine: Sodium Channel Blocker for Advanced Epilepsy...

  2025-12-26

  Lamotrigine, a high-purity sodium channel blocker and 5-HT inhibitor, enables robust workflows in epilepsy and cardiac sodium current modulation research. With validated BBB permeability and a proven role in both in vitro and preclinical models, Lamotrigine from APExBIO sets a new standard for translational neuroscience and arrhythmia studies.

11369 records 12/758 page Previous Next First page 上5页 1112131415 下5页 Last page